Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant What is This Site Help Center Crisis
Powered By

Top 6 search results for "Blenrep" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
Immunotherapy for Multiple Myeloma: What To Know
... Blenrep also targets myeloma for destruction by other cells in the immune system, including natural killer cells. Side Effects of ImmunotherapyMonoclonal antibodies are usually given intravenously (by IV). Monoclonal antibody therapy typically has less harsh side effects compared to chemotherapy. ...
Immunotherapy for Multiple Myeloma: What To Know
... Blenrep also targets myeloma for destruction by other cells in the immune system, including natural killer cells. Side Effects of ImmunotherapyMonoclonal antibodies are usually given intravenously (by IV). Monoclonal antibody therapy typically has less harsh side effects compared to chemotherapy. ...
Myeloma Treatment Journey: From First Line to Fourth Line
... Currently, Blenrep is used as part of combination therapies to improve treatment response.At this phase, your healthcare team will also prioritize symptom control, bone health, and emotional well-being. ...
Myeloma Treatment Journey: From First Line to Fourth Line
... Currently, Blenrep is used as part of combination therapies to improve treatment response.At this phase, your healthcare team will also prioritize symptom control, bone health, and emotional well-being. ...
8 Refractory Myeloma Therapies: Know Your Treatment Options
... Food and Drug Administration Withdrawal of Blenrep from the US Market — International Myeloma Foundation FDA Approves Belantamab Mafodotin-Blmf for Relapsed or Refractory Multiple Myeloma — U.S. ...
8 Refractory Myeloma Therapies: Know Your Treatment Options
... Food and Drug Administration Withdrawal of Blenrep from the US Market — International Myeloma Foundation FDA Approves Belantamab Mafodotin-Blmf for Relapsed or Refractory Multiple Myeloma — U.S. ...
What Is BCMA-Targeted Immunotherapy? (VIDEO)
... The brand name formulation Blenrep was pulled from the U.S. market in 2022, but the FDA approved it again on Oct. 23, 2025.It’s approved in combination with bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma after at least two prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug.Blenrep ...
What Is BCMA-Targeted Immunotherapy? (VIDEO)
... The brand name formulation Blenrep was pulled from the U.S. market in 2022, but the FDA approved it again on Oct. 23, 2025.It’s approved in combination with bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma after at least two prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug.Blenrep ...
New Treatment Options for Relapsed or Refractory Myeloma
... The monoclonal antibody helps bring the cell-killing chemotherapy in contact with cancer cells.The FDA approved a medication in this category — belantamab mafodotin (Blenrep) — in August 2020. This medication targets a protein called B-cell maturation antigen (BCMA), found on myeloma cells. ...
New Treatment Options for Relapsed or Refractory Myeloma
... The monoclonal antibody helps bring the cell-killing chemotherapy in contact with cancer cells.The FDA approved a medication in this category — belantamab mafodotin (Blenrep) — in August 2020. This medication targets a protein called B-cell maturation antigen (BCMA), found on myeloma cells. ...
Chemotherapy for Multiple Myeloma: Your Guide
... The myeloma drug belantamab mafodotin-blmf (Blenrep) works differently. This medication consists of a monoclonal antibody that recognizes a protein called B-cell maturation antigen (or BCMA). The antibody is attached to a chemotherapy drug. ...
Chemotherapy for Multiple Myeloma: Your Guide
... The myeloma drug belantamab mafodotin-blmf (Blenrep) works differently. This medication consists of a monoclonal antibody that recognizes a protein called B-cell maturation antigen (or BCMA). The antibody is attached to a chemotherapy drug. ...